| Ago 2 | Argonaute 2 |
| ALT | Alternative Lengthening of Telomeres |
| ddPCR | Digital Droplet Polymerase Chain Reaction |
| EMT | Epithelial-Mesenchymal Transition |
| ER | Estrogen Receptors |
| EVs | Extracellular vesicles |
| HDL | High-density Lipoproteins |
| HPF | High-power fields |
| LNA | Locked Nucleic Acid |
| miRNAs | microRNAs |
| MRI | Magnetic Resonance Imaging |
| mRNAs | Messenger RNAs |
| NGS | Next Generation Sequencing |
| oncomiRs | Oncogenic miRNAs |
| OS | Overall Survival |
| PARP | poly(ADP-ribose) polymerase |
| PR | Progesterone Receptors |
| Pre-miRNAs | Precursor miRNAs |
| Pri-miRNAs | Primary miRNAs |
| RISC | RNA-induced Silencing Complex |
| RT-qPCR | Reverse transcription followed by quantitative Polymerase Chain Reaction |
| SMA | Smooth Muscle Actin |
| STUMP | Smooth Muscle Tumors of Uncertain Malignant Potential |
| TME | Tumor Microenvironment |
| uLMS | Uterine leiomyosarcoma |